A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

M Ozaka, H Ishii, T Sato, M Ueno, M Ikeda… - Cancer chemotherapy …, 2018 - Springer
Background We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for
chemotherapy-naïve patients with metastatic pancreatic cancer. Methods Patients with …
被引用次数：139 相关文章

[引用][C] A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

M Ozaka, H Ishii, T Sato, M Ueno, M Ikeda… - Cancer Chemotherapy …, 2018 - cir.nii.ac.jp

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

M Ozaka, H Ishii, T Sato, M Ueno… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Background We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for
chemotherapy-naïve patients with metastatic pancreatic cancer. Methods Patients with …

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer.

M Ozaka, H Ishii, T Sato, M Ueno, M Ikeda… - Cancer …, 2018 - europepmc.org
Background We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for
chemotherapy-naïve patients with metastatic pancreatic cancer. Methods Patients with …

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

M Ozaka, H Ishii, T Sato, M Ueno… - Cancer …, 2018 - search.proquest.com
Background We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for
chemotherapy-naïve patients with metastatic pancreatic cancer. Methods Patients with …